Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
Odonate Therapeutics reports 2019 executive compensation
By ExecPay News
Published: May 15, 2020
Odonate Therapeutics reported fiscal year 2019 executive compensation information on May 15, 2020.
In 2019, three executives at Odonate Therapeutics received on average a compensation package of $1.2M, a 53% increase compared to previous year.
Average pay of disclosed executives at Odonate Therapeutics
Joseph P. O'Connell, Chief Medical Officer, received $2M in total, which increased by 37% compared to 2018. 72% of O'Connell's compensation, or $1.4M, was in option awards. O'Connell also received $153K in non-equity incentive plan, $364K in salary, as well as $29K in other compensation.
John Lemkey, Chief Operating Officer, received a compensation package of $1.5M, which increased by 79% compared to previous year. 71% of the compensation package, or $1.1M, was in option awards.
Kevin C. Tang, Chief Executive Officer, earned $1 in 2019, which is the same as previous year.
Related executives
You may also like
Source: SEC filing on May 15, 2020.